Westover Capital Advisors, LLC Astrazeneca PLC Transaction History
Westover Capital Advisors, LLC
- $513 Million
- Q3 2024
A detailed history of Westover Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 10,835 shares of AZN stock, worth $698,207. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,835
Previous 11,187
3.15%
Holding current value
$698,207
Previous $872,000
3.21%
% of portfolio
0.16%
Previous 0.23%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...